Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Biospecifics Tech Cp (BSTC)

Biospecifics Tech Cp (BSTC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 417,122
  • Shares Outstanding, K 7,345
  • Annual Sales, $ 38,190 K
  • Annual Income, $ 24,470 K
  • 60-Month Beta 0.69
  • Price/Sales 10.69
  • Price/Cash Flow 16.46
  • Price/Book 3.15

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 0.19
  • Number of Estimates 1
  • High Estimate 0.19
  • Low Estimate 0.19
  • Prior Year 0.85
  • Growth Rate Est. (year over year) -77.65%

Price Performance

See More
Period Period Low Period High Performance
1-Month
52.39 +2.85%
on 09/21/20
66.80 -19.34%
on 08/25/20
-11.28 (-17.31%)
since 08/21/20
3-Month
52.39 +2.85%
on 09/21/20
69.73 -22.73%
on 08/10/20
-6.70 (-11.06%)
since 06/19/20
52-Week
42.00 +28.29%
on 03/23/20
69.73 -22.73%
on 08/10/20
-3.87 (-6.70%)
since 09/20/19

Most Recent Stories

More News
The Keys to Successfully Timing the Markets - September 15, 2020

Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?

CSBR : 8.50 (-6.70%)
RDNT : 14.84 (-6.49%)
BSTC : 53.51 (-5.78%)
TRXC : 0.3475 (-5.44%)
CMD : 43.01 (+0.16%)
BioSpecifics to Present at the Virtual Oppenheimer & Co. Fall Healthcare Life Sciences and MedTech Summit

, /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class collagenase-based...

MHMNF : 54.5000 (unch)
BSTC : 53.51 (-5.78%)
BioSpecifics to Present at the H.C. Wainwright Virtual Healthcare Conference

, /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class collagenase-based...

BSTC : 53.51 (-5.78%)
The Keys to Successfully Timing the Markets - August 18, 2020

Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?

RDNT : 14.84 (-6.49%)
BSTC : 53.51 (-5.78%)
TRXC : 0.3475 (-5.44%)
CSBR : 8.50 (-6.70%)
CMD : 43.01 (+0.16%)
New Strong Sell Stocks for August 14th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.

JOBS : 79.17 (-0.04%)
BSTC : 53.51 (-5.78%)
BAP : 126.08 (-2.15%)
HCAP : 3.37 (+0.90%)
DSSI : 7.34 (-5.41%)
Catalyst's (CPRX) Q2 Earnings & Revenues Beat Estimates

Catalyst (CPRX) beats both earnings and sales estimates in the second quarter of 2020.

BLRX : 1.6900 (-3.43%)
ACRX : 1.8100 (+15.29%)
BSTC : 53.51 (-5.78%)
CPRX : 3.21 (-4.46%)
BioSpecifics Technologies (BSTC) Surpasses Q2 Earnings and Revenue Estimates

BioSpecifics (BSTC) delivered earnings and revenue surprises of 320.00% and 89.47%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

BSTC : 53.51 (-5.78%)
BioSpecifics Reports Second Quarter 2020 Financial and Operating Results

, /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class collagenase-based...

BSTC : 53.51 (-5.78%)
Analysts Estimate BioSpecifics Technologies (BSTC) to Report a Decline in Earnings: What to Look Out for

BioSpecifics (BSTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BSTC : 53.51 (-5.78%)
The Truth About Market Timing - June 17, 2020

Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?

TRXC : 0.3475 (-5.44%)
RDNT : 14.84 (-6.49%)
BSTC : 53.51 (-5.78%)
CSBR : 8.50 (-6.70%)
CMD : 43.01 (+0.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Trade BSTC with:

Business Summary

BIOSPECIFICS TECHNOLOGIES is engaged in the business of producing and licensing, for sale by other, a U.S. Food and Drug Administration (``FDA``) approved enzyme derived from collagenase, named Collagenase ABC, and researching, developing and clinically testing additional products derived therefrom for...

See More

Key Turning Points

2nd Resistance Point 58.68
1st Resistance Point 57.73
Last Price 53.51
1st Support Level 55.30
2nd Support Level 53.81

See More

52-Week High 69.73
Fibonacci 61.8% 59.14
Fibonacci 50% 55.87
Last Price 53.51
Fibonacci 38.2% 52.59
52-Week Low 42.00

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar